
Table 3: Glycated haemoglobin parameters and incidence of discontinuations due to treatment-emergent adverse events (TEAEs) by study
Table 3: Glycated haemoglobin parameters and incidence of discontinuations due to treatment-emergent adverse events (TEAEs) by study